Taken together, our study revealed the novel findings that tumour‐suppressive SIRT2 is a direct functional target gene of miR‐212‐5p and that the miR‐212‐5p/SIRT2 axis is a promising prognostic factor and potential therapeutic target in CRC. Here, SIRT2 is linked to neoplasm.